Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB – Markets Insider
|
Alligator Bioscience Signs Immunotherapy Research Collaboration Agreement for 4-1BB
Markets Insider Alligator Bioscience (Nasdaq Stockholm: ATORX), a biotechnology company developing antibody-based pharmaceuticals for tumor-directed immunotherapy, announced today that a research collaboration agreement has been signed with Professor Ignacio … |
